ArticleVaccines2023

The Real-World Study of Immunogenicity and Safety of the Adjuvant Recombinant Vaccine against Varicella Zoster Virus in Patients with Immune-Mediated Inflammatory Diseases Treated with Janus Kinase Inhibitors.

Ana Esteban-Vazquez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.